Avnet Inc. is one of the world's largest distributors of electronic components and computer products. It serves original equipment manufacturers, electronic manufacturing services providers, original design manufacturers, and value-added resellers. Avnet maintains an extensive inventory, including electronic products and system manufacturers. Avnet distributes products for companies like IBM and Hewlett-Packard Co. Avnet has two major operating segments: Electronic Components (EC) & Premier Farnell (PF). The EC unit distributes semiconductors and Interconnect, passive and electromechanical devices, and provides supply chain management, inventory replenishment system and non-complex engineering design services and integrated solutions like technical design, integration and assembly of embedded products, systems and solutions for industrial applications. Avnet's PF unit provides a comprehensive suite of kits, tools, electronic components and industrial automation components to both engineers and entrepreneurs....
+See More2022-03-05 09:27:00 Saturday ET

Addendum on empirical tests of multi-factor models for asset return prediction Fama and French (2015) propose an empirical five-factor asset pricing mode
2018-07-09 09:39:00 Monday ET

The Federal Reserve raises the interest rate again in mid-2018 in response to 2% inflation and wage growth. The current neutral interest rate hike neither b
2019-01-09 07:33:00 Wednesday ET

Apple revises down its global sales revenue estimate to $83 billion due to subpar smartphone sales in China. Apple CEO Tim Cook points out the fact that he
2018-06-07 10:36:00 Thursday ET

AT&T wins court approval to take over Time Warner with a trademark $85 billion bid despite the Trump administration prior dissent due to antitrust conce
2023-07-28 11:28:00 Friday ET

Lucian Bebchuk and Jesse Fried critique that executive pay often cannot help explain the stock return and operational performance of most U.S. public corpor
2026-10-31 12:38:00 Saturday ET

Today tech titans and billionaires continue to reshape global pharmaceutical investments for both better healthspan and longer lifespan. We discuss, desc